Literature DB >> 15109500

Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain?

Rae F Bell, Eija Kalso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15109500     DOI： 10.1016/j.pain.2003.10.002

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  4 in total

1.  Some thoughts on curing noncancer chronic pain with opioids.

Authors:  James Gibson; Michael Achong; David Higgins; Susan Abbey; Emil Zamora; Richard G Marlin; Flora Yeracaris
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

2.  The analgesic effect of combined treatment with intranasal S-ketamine and intranasal midazolam compared with morphine patient-controlled analgesia in spinal surgery patients: a pilot study.

Authors:  Christine Riediger; Manuel Haschke; Christoph Bitter; Thomas Fabbro; Stefan Schaeren; Albert Urwyler; Wilhelm Ruppen
Journal:  J Pain Res       Date:  2015-02-13       Impact factor: 3.133

3.  Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia.

Authors:  Kenneth C Hohmeier; Lyndsey M Almon
Journal:  Case Rep Med       Date:  2015-04-09

4.  Intranasal Ketamine for the Management of Incidental Pain during Wound Dressing in Cancer Patients: A Pilot Study.

Authors:  Nivedita Page; Vivek Nirabhawane
Journal:  Indian J Palliat Care       Date:  2018 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.